Cigna Banned From Medicare Sales for `Systemic Failures'
- U.S. says Cigna has `longstanding history of non-compliance'
- Anthem, which agreed to buy Cigna, remains committed to deal
This article is for subscribers only.
Cigna Corp. was banned from marketing its Medicare products to new customers after the U.S. found deficiencies in how the health insurer ran its plans, citing widespread violations that the government said threatened patients’ health.
“Cigna has experienced widespread and systemic failures impacting Cigna enrollees’ ability to access medical services and prescription medications,” the U.S. said in a Jan. 21 letter to the insurer outlining the sanctions. “Cigna has had a longstanding history of non-compliance” with requirements from the Centers for Medicare and Medicaid Services, or CMS.